scholarly journals Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

2017 ◽  
Vol 117 (1) ◽  
pp. 8-14 ◽  
Author(s):  
F Koinis ◽  
S Agelaki ◽  
V Karavassilis ◽  
N Kentepozidis ◽  
E Samantas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Research Group ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Multicentre Phase ◽  
Oncology Research

A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Oncology ◽  
2019 ◽  
Vol 97 (6) ◽  
pp. 327-333
Author(s):  
Satoshi Ikeda ◽  
Hiroshige Yoshioka ◽  
Toshihiko Kaneda ◽  
Toshihide Yokoyama ◽  
Takashi Niwa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Research Group ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Research

scholarly journals Vinorelbine alternating oral and intravenous plus carboplatinin advanced non-small-cell lung cancer: results of a multicentre phase II study

2004 ◽  
Vol 15 (6) ◽  
pp. 921-927 ◽  
Author(s):  
M.E.R. O’Brien ◽  
A. Szczesna ◽  
H. Karnicka ◽  
P. Zatloukal ◽  
T. Eisen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicentre Phase
Sign in / Sign up

Export Citation Format

Share Document